Press Releases

BUFFALO, NY — From its seminal studies in the first half of the 20th century linking tobacco use and cancer incidence to its latest findings on electronic cigarettes, Roswell Park Comprehensive Cancer Center (Roswell Park) has been a major force in tobac

PHILADELPHIA — Treatment with the drug decitabine prior to administration of chemotherapy and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, suggesting that this combinatorial chemoimmunotherapy may provide a new treatment option for patients with this disease,

BUFFALO, NY — On January 20 after morning practice, five Buffalo Sabres will shave their heads in front of cancer patients and fans to show their support of people in our community who are fighting cancer.  

BUFFALO, NY — A team led by Fengzhi Li, PhD, of Roswell Park Comprehensive Cancer Center has reported significant new findings regarding the chemical structure of the novel anticancer agent FL118.

BUFFALO, NY — Proteins called fibroblast growth factor receptors (FGFRs) have been implicated in the development of pancreatic cancer, which remains difficult to treat.

Roswell Park Comprehensive Cancer Center announces two key executive appointments: Armen Gallucci, FACHE, has joined Roswell Park as Vice President of Business Development and Outreach, and Kerry L. Kerlin has been named Chief Information Officer.